US OKs Kodak's first mammography CAD (computer-aided detection) technology:
This article was originally published in Clinica
Executive Summary
Eastman Kodak has received FDA clearance to sell its mammography computer-aided detection (CAD) system in the US. The product is Kodak's first CAD system developed for breast cancer detection and will be available immediately, the company said. CAD is a digital software technology designed to aid the detection of early stage breast cancer and is used as an adjunct to mammography. Kodak said that results from a clinical trial submitted to the FDA found that 39.4% of breast cancers that are missed could have been detected 14.8 months earlier using its CAD technology. Approximately 95% of patient mammography images in the US are still captured on X-ray film, the company said.
You may also be interested in...
Probiotics And Cold Remedies Boost Recordati In 2023
Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.
Falling Sales Force New Priorities At Roche
The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re out.
Human Cell-Secreted Proteins Offer A Wellspring Of Potential Therapeutics
CEO Hanadie Yousef leads Juvena Therapeutics in utilizing an AI-based platform that analyzes cell-secreted proteins to identify potential therapeutics. One of their first near-clinical assets could complement GLP-1s.